Henry Nordhoff

Henry Nordhoff

Directeur Général chez
Banyan Biomarkers, Inc.
84 ans
Health Technology
Consumer Services
Health Services

Profil

Henry L.
Nordhoff
is currently the Chairman & Chief Executive Officer at Banyan Biomarkers, Inc. He is also the Chairman at Chugai Pharma USA LLC, Chairman at Proactive Diagnostics, and a Trustee at Sanford Burnham Prebys Medical Discovery Institute.
Previously, he was the President & Chief Executive Officer at Targetech, Inc. and the Non-Executive Chairman at Gen-Probe, Inc. He also served as the Executive Chairman at Cypher Genomics, Inc. and as an Independent Director at Lineage Cell Therapeutics, Inc., MannKind Corp., and Asterias Biotherapeutics, Inc. Additionally, he was the Managing Director at Shipston Group Ltd. Nordhoff holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from The Johns Hopkins University.

Postes actifs de Henry Nordhoff

SociétésPosteDébut
Président 16/05/2011
Directeur Général -
Directeur/Membre du Conseil -
Président 01/01/2013

Anciens postes connus de Henry Nordhoff

SociétésPosteFin
ASTERIAS BIOTHERAPEUTICS INC Directeur/Membre du Conseil 10/04/2014
LINEAGE CELL THERAPEUTICS, INC. Directeur/Membre du Conseil 07/04/2014
Directeur Général 17/05/2009
Président -
Private Equity Investor -
Voir l'expérience en détail de Henry Nordhoff

Formation de Henry Nordhoff

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Services

Distribution Services

Health Services

Health Technology

Finance

Technology Services

  1. Bourse
  2. Insiders
  3. Henry Nordhoff